Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine.
about
Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunityTargeting the intragraft microenvironment and the development of chronic allograft rejectionAccelerated wound healing by mTOR activation in genetically defined mouse models.Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risksPeriostin responds to mechanical stress and tension by activating the MTOR signaling pathway.Acute respiratory failure in kidney transplant recipients: a multicenter study.Transcriptional regulation of gene expression during osmotic stress responses by the mammalian target of rapamycin.Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice.Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseasesSignal transduction via the T cell antigen receptor in naïve and effector/memory T cells.An evaluation of sirolimus in renal transplantation.The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses.Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy.Molecular pathways: PI3K pathway phosphatases as biomarkers for cancer prognosis and therapyRapamycin-induced posterior reversible encephalopathy in a kidney transplantation patient.Gastrointestinal disorders after immunosuppression: an experimental model to evaluate the influence of monotherapy on motility parameters.The clinical value of enzyme-multiplied immunoassay technique monitoring the plasma concentrations of cyclosporine A after renal transplantation.
P2860
Q24610550-9B549123-DAB0-42BA-8E4A-D352C27B8083Q26852762-56021EFC-037D-43B5-AA03-2741230C6E4AQ30389607-5451E5DC-B62C-4659-B276-3F991DEFB46EQ34316147-9BD18D3F-9CDC-4349-9756-62C207E6C604Q35071033-E4726E81-4366-40DA-ABDD-267662C8F642Q35559431-38945469-68AE-401D-AFC8-C613E375E76DQ36044804-1D851FDC-9F0E-459A-9D37-EF22304243CEQ36338250-E32F764D-8855-4DAD-A59E-941B52FF8CCBQ36425959-A7CE636D-C453-425B-B3F9-AF75F443D118Q36495930-3971864C-B227-4158-A0AE-94AE6BAF7390Q38038696-4B83E511-DC38-42BC-A6CA-D69C6F8BE96EQ38115702-2F8CEE4C-3F12-4D06-AAB1-EE9B97B5DD59Q38895113-0647F985-96AD-42F2-AF98-BAFC74C8E2F8Q40740686-0AB0F523-DAE1-43C9-8896-5B636ED74CACQ48180004-90F92A94-677D-4F4D-9EC3-724AB5A7360FQ48362118-5357EA58-FEFF-4AF9-9FA8-FD419A658F2FQ50043110-8A5E5284-B515-465B-9A62-E710381A2924
P2860
Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Fifteen years of clinical stud ...... combination with cyclosporine.
@ast
Fifteen years of clinical stud ...... combination with cyclosporine.
@en
type
label
Fifteen years of clinical stud ...... combination with cyclosporine.
@ast
Fifteen years of clinical stud ...... combination with cyclosporine.
@en
prefLabel
Fifteen years of clinical stud ...... combination with cyclosporine.
@ast
Fifteen years of clinical stud ...... combination with cyclosporine.
@en
P1476
Fifteen years of clinical stud ...... combination with cyclosporine.
@en
P2093
P304
P356
10.1016/J.TRANSPROCEED.2008.10.019
P407
P433
P577
2008-12-01T00:00:00Z